Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819728 · ClinicalTrials.gov registry record · Phase 2

Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer

A Phase 2 study of Carcinoma, Non-Small Cell Lung, sponsored by Sanofi.

Completed
Registry status
Phase 2
Development phase
35
Enrollment target
1
Study location

NCT00819728 is a Phase 2 study of Carcinoma, Non-Small Cell Lung that has completed, run by Sanofi. The registered enrollment target is 35 participants, below the 324-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819728, a Phase 2 study of Carcinoma, Non-Small Cell Lung, has completed, sponsored by Sanofi.

COMPLETED
Registry status
Phase 2
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The main purpose of the study is to determine the activity of the weekly combination of docetaxel (Taxotere) and irinotecan in terms of response rate in subjects with advanced, previously untreated, non-small cell lung cancer. It is also to determine the activity of this combination in terms of response duration, time to progression, median survival, overall survival, and percent one-year survival, as well as the side-effect and toxicity profile of weekly Taxotere and weekly irinotecan.

Conditions Studied

Carcinoma, Non-Small Cell Lung

Interventions

  • DRUG Docetaxel
  • DRUG Irinotecan

Study Locations (1)

New Jersey

  • Sanofi-Aventis US - Bridgewater

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2000-06
Est. Completion 2003-01
Phase Phase 2

Sponsor

Sanofi

713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00819728

The ClinicalTrials.gov registry entry for NCT00819728 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 324-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (89% lower). The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 2 interventions - of which Docetaxel is the first listed.

NCT00819728 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00819728 about?

NCT00819728 is a clinical study titled "Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer". The main purpose of the study is to determine the activity of the weekly combination of docetaxel (Taxotere) and irinotecan in terms of response rate in subjects with advanced, previously untreated, non-small cell lung cancer. It is also to determine the activity of this combination in terms of resp...

What is the current status of trial NCT00819728?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2000-06. Estimated completion is 2003-01.

What conditions does trial NCT00819728 study?

This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung.

What interventions are being tested in trial NCT00819728?

The interventions under investigation include: Docetaxel (DRUG), Irinotecan (DRUG).

Who is sponsoring clinical trial NCT00819728?

This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00819728 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Non-Small Cell Lung

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Non-Small Cell Lung

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.